Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor.
about
Bone Marrow Gene Therapy for HIV/AIDSEngineering T Cells to Functionally Cure HIV-1 InfectionA universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor.RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.Stem cell-based anti-HIV gene therapy.Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino TerminusGenetic therapies against HIV.Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance.Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.Novel cell and gene therapies for HIV.Gene therapy for HIV infection.Potential mechanisms for cell-based gene therapy to treat HIV/AIDS.Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.Cell and Gene Therapy for HIV Cure.Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.
P2860
Q26801765-C3F859FA-7C91-497A-B9F9-FB98651C6D74Q28086801-DEBA1DE2-2BE5-411A-90F5-063E4D8699C9Q34030602-0234DC4A-2445-49C2-B4E7-A713721A586BQ34121209-F9139B85-2A08-4A58-A893-1A1BA00AD44BQ34748489-F76BF48F-FAD4-47E5-BBD5-F55444A6356FQ34769333-2A1AF0DE-2C6D-4616-B64A-F8BE78D6E075Q36195192-229403AB-7935-4447-88D9-AF4CFBB4EEA4Q37027170-7E752669-6B9D-4910-A05E-AE0D8482A09EQ37256197-B069E8D5-8797-47AE-A123-5DD870989BE5Q37593222-71744E94-CDC9-4528-8D7F-DF9F20FDA752Q38048762-58347D9A-C591-4DD4-9011-6E4B6CB9811BQ38260902-5F575CE5-F2DF-4736-857C-6238DE5CD8B8Q38267240-11F9F094-9844-4FF4-B280-CD8CE07F1837Q38777005-B7BDEEB0-D380-4BDA-9E2B-255CFB07C296Q42029999-2E7114CA-28A1-41E6-9C21-016A31BD3FA3Q47236016-6A1E4A67-2577-421C-AC97-EC648A7BF56BQ50878341-B1163A50-2C08-4855-AA86-4288AB15235C
P2860
Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Suppression of HIV-1 infection ...... gp41-derived fusion inhibitor.
@en
Suppression of HIV-1 infection ...... gp41-derived fusion inhibitor.
@nl
type
label
Suppression of HIV-1 infection ...... gp41-derived fusion inhibitor.
@en
Suppression of HIV-1 infection ...... gp41-derived fusion inhibitor.
@nl
prefLabel
Suppression of HIV-1 infection ...... gp41-derived fusion inhibitor.
@en
Suppression of HIV-1 infection ...... gp41-derived fusion inhibitor.
@nl
P2093
P1433
P1476
Suppression of HIV-1 infection ...... gp41-derived fusion inhibitor.
@en
P2093
P356
10.1016/J.CLIM.2005.02.019
P577
2005-04-01T00:00:00Z